These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12535702)

  • 1. Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease.
    Banks WA; Terrell B; Farr SA; Robinson SM; Nonaka N; Morley JE
    Peptides; 2002 Dec; 23(12):2223-6. PubMed ID: 12535702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.
    Banks WA; Farr SA; Morley JE; Wolf KM; Geylis V; Steinitz M
    Exp Neurol; 2007 Aug; 206(2):248-56. PubMed ID: 17582399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein.
    Banks WA; Farr SA; Butt W; Kumar VB; Franko MW; Morley JE
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1113-21. PubMed ID: 11356936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences in PACAP transport across the blood-brain barrier in mice: a possible influence of strain, amyloid beta protein, and age.
    Nonaka N; Banks WA; Mizushima H; Shioda S; Morley JE
    Peptides; 2002 Dec; 23(12):2197-202. PubMed ID: 12535699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to beta-amyloid decrease the blood-to-brain transfer of beta-amyloid peptide.
    Pan W; Solomon B; Maness LM; Kastin AJ
    Exp Biol Med (Maywood); 2002 Sep; 227(8):609-15. PubMed ID: 12192102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Pardridge WM
    Bioconjug Chem; 2007; 18(2):447-55. PubMed ID: 17315944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
    Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
    J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.
    Rotman M; Welling MM; van den Boogaard ML; Moursel LG; van der Graaf LM; van Buchem MA; van der Maarel SM; van der Weerd L
    Nucl Med Biol; 2015 Aug; 42(8):695-702. PubMed ID: 25960433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy.
    Gustafsson S; Gustavsson T; Roshanbin S; Hultqvist G; Hammarlund-Udenaes M; Sehlin D; Syvänen S
    Neuropharmacology; 2018 Dec; 143():1-9. PubMed ID: 30201212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
    Dickstein DL; Biron KE; Ujiie M; Pfeifer CG; Jeffries AR; Jefferies WA
    FASEB J; 2006 Mar; 20(3):426-33. PubMed ID: 16507760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a behaviorally active antibody on the brain uptake and clearance of amyloid beta proteins.
    Banks WA; Pagliari P; Nakaoke R; Morley JE
    Peptides; 2005 Feb; 26(2):287-94. PubMed ID: 15629540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope-dependent effects of Beta-amyloid antibodies on Beta-amyloid clearance in an in vitro model of the blood-brain barrier.
    Bachmeier CJ; Beaulieu-Abdelahad D; Mullan MJ; Paris D
    Microcirculation; 2011 Jul; 18(5):373-9. PubMed ID: 21418385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's disease.
    Solomon B
    Rejuvenation Res; 2008 Apr; 11(2):349-57. PubMed ID: 18341423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
    Asami-Odaka A; Obayashi-Adachi Y; Matsumoto Y; Takahashi H; Fukumoto H; Horiguchi T; Suzuki N; Shoji M
    Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine receptor signaling modulates permeability of the blood-brain barrier.
    Carman AJ; Mills JH; Krenz A; Kim DG; Bynoe MS
    J Neurosci; 2011 Sep; 31(37):13272-80. PubMed ID: 21917810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's Disease.
    Chang R; Knox J; Chang J; Derbedrossian A; Vasilevko V; Cribbs D; Boado RJ; Pardridge WM; Sumbria RK
    Mol Pharm; 2017 Jul; 14(7):2340-2349. PubMed ID: 28514851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.
    Rotman M; Welling MM; Bunschoten A; de Backer ME; Rip J; Nabuurs RJ; Gaillard PJ; van Buchem MA; van der Maarel SM; van der Weerd L
    J Control Release; 2015 Apr; 203():40-50. PubMed ID: 25668771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier.
    Poduslo JF; Curran GL
    Neuroreport; 2001 Oct; 12(15):3197-200. PubMed ID: 11711855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.